Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids.

Alkylphosphocholines Antiparasitic hybrid compounds Dinitroanilines Leishmania sp. Molecular docking trypanosomatid tubulin Trypanosomatids

Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 03 2023
revised: 05 05 2023
accepted: 15 05 2023
medline: 10 7 2023
pubmed: 28 5 2023
entrez: 27 5 2023
Statut: ppublish

Résumé

A series of nine novel ether phospholipid-dinitroaniline hybrids were synthesized in an effort to deliver more potent antiparasitic agents with improved safety profile compared to miltefosine. The compounds were evaluated for their in vitro antiparasitic activity against L. infantum, L.donovani, L. amazonensis, L. major and L. tropica promastigotes, L. infantum and L. donovani intracellular amastigotes, Trypanosoma brucei brucei and against different developmental stages of Trypanosoma cruzi. The nature of the oligomethylene spacer between the dinitroaniline moiety and the phosphate group, the length of the side chain substituent on the dinitroaniline and the choline or homocholine head group were found to affect both the activity and toxicity of the hybrids. The early ADMET profile of the derivatives did not reveal major liabilities. Hybrid 3, bearing an 11-carbon oligomethylene spacer, a butyl side chain and a choline head group, was the most potent analogue of the series. It exhibited a broad spectrum antiparasitic profile against the promastigotes of New and Old World Leishmania spp., against intracellular amastigotes of two L. infantum strains and L. donovani, against T. brucei and against T. cruzi Y strain epimastigotes, intracellular amastigotes and trypomastigotes. The early toxicity studies revealed that hybrid 3 showed a safe toxicological profile while its cytotoxicity concentration (CC

Identifiants

pubmed: 37244229
pii: S0045-2068(23)00276-6
doi: 10.1016/j.bioorg.2023.106615
pii:
doi:

Substances chimiques

Antiparasitic Agents 0
Antiprotozoal Agents 0
Phospholipid Ethers 0
homocholine 10238-59-2
Choline N91BDP6H0X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106615

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marina Roussaki (M)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: mroussaki@eie.gr.

George E Magoulas (GE)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: gmagoulas@eie.gr.

Theano Fotopoulou (T)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: tfotop@eie.gr.

Nuno Santarem (N)

i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; IBMC-Instituto de Biologia Molecular e Celular, Parasite Disease Group, Porto, Portugal. Electronic address: santarem@ibmc.up.pt.

Emile Barrias (E)

Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho s/n, Ilha do Fundão, 21941-900 Rio de Janeiro, Brazil. Electronic address: emilebarrias@gmail.com.

Ina Pöhner (I)

School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Electronic address: ina.pohner@uef.fi.

Sara Luelmo (S)

i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. Electronic address: sluelmo@i3s.up.pt.

Pantelis Afroudakis (P)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: pafroudakischem@yahoo.gr.

Kalliopi Georgikopoulou (K)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: k.georgikopoulou@access-one.gr.

Paloma Tejera Nevado (PT)

Bernhard Nocht Institute for Tropical Medicine, Leishmania Genetics Group, Bernhard Nocht St 74, D-20359 Hamburg, Germany. Electronic address: paloma.tejera.nevado@gu.se.

Julia Eick (J)

Bernhard Nocht Institute for Tropical Medicine, Leishmania Genetics Group, Bernhard Nocht St 74, D-20359 Hamburg, Germany. Electronic address: Julia.Eick@gmx.de.

Eugenia Bifeld (E)

Bernhard Nocht Institute for Tropical Medicine, Leishmania Genetics Group, Bernhard Nocht St 74, D-20359 Hamburg, Germany. Electronic address: eugeniabifeld@gmail.com.

María J Corral (MJ)

Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain. Electronic address: mjcorralcaridad@gmail.com.

María Dolores Jiménez-Antón (MD)

Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain. Electronic address: mariadolores.jimenez@ucm.es.

Bernhard Ellinger (B)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Hamburg, Germany; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg, Germany. Electronic address: Bernhard.Ellinger@itmp.fraunhofer.de.

Maria Kuzikov (M)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Hamburg, Germany; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg, Germany. Electronic address: Maria.Kuzikov@itmp.fraunhofer.de.

Irini Fragiadaki (I)

University of Crete, Faculty of Medicine, Department of Clinical Microbiology and Microbial Pathogenesis, Voutes University Campus, 70013 Heraklion, Crete, Greece. Electronic address: fragiada@med.uoc.gr.

Effie Scoulica (E)

University of Crete, Faculty of Medicine, Department of Clinical Microbiology and Microbial Pathogenesis, Voutes University Campus, 70013 Heraklion, Crete, Greece. Electronic address: e.scoulica@uoc.gr.

Sheraz Gul (S)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Hamburg, Germany; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg, Germany. Electronic address: Sheraz.Gul@itmp.fraunhofer.de.

Joachim Clos (J)

Bernhard Nocht Institute for Tropical Medicine, Leishmania Genetics Group, Bernhard Nocht St 74, D-20359 Hamburg, Germany. Electronic address: clos@bnitm.de.

Kyriakos C Prousis (KC)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: kyrprous@eie.gr.

Juan J Torrado (JJ)

Department of Pharmaceutics and Food Technology, Complutense University of Madrid, 28240 Madrid, Spain. Electronic address: torrado1@farm.ucm.es.

José María Alunda (JM)

Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain. Electronic address: jmalunda@ucm.es.

Rebecca C Wade (RC)

Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), D-69118 Heidelberg, Germany; Center for Molecular Biology (ZMBH), DKFZ-ZMBH Alliance, and Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, D-69120 Heidelberg, Germany. Electronic address: rebecca.wade@h-its.org.

Wanderley de Souza (W)

Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho s/n, Ilha do Fundão, 21941-900 Rio de Janeiro, Brazil. Electronic address: wsouza@biof.ufrj.br.

Anabela Cordeiro da Silva (A)

IBMC-Instituto de Biologia Molecular e Celular, Parasite Disease Group, Porto, Portugal; Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Departmento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal. Electronic address: cordeiro@ibmc.up.pt.

Theodora Calogeropoulou (T)

National Hellenic Research Foundation, Institute of Chemical Biology, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece. Electronic address: tcalog@eie.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH